research.io
CCancer3/15/2026

Reduced induction dose of daunorubicin is a potential standard for pediatric patients with ALL

Leah Lawrence
Read at Cancer
Tags
Acute Lymphoblastic Leukemia researchPublic Health, Environmental and Occupational Health